CSIR-CDRI Collaborates With Cipla For Drug Discovery

xt-align: center;">CDRI Collaborates With Cipla

The CSIR-Central Drug Research Institute (CDRI) has collaborated with Cipla Limited to jointly develop new drugs for treating various medical conditions as well as the repurposing of drugs for India & global markets.

Dr. Tapas K Kundu, Director, CDRI, said that this is a great moment for CSIR-CDRI, the premiere drug development and research institute of the country to establish collaboration for the affordable healthcare program and repurposing of drugs not only for India but also for the global markets in partnership and active participation from Cipla.

CDRI Collaborates With Cipla: Global Drug Discovery Partnership

Cipla’s association with CSIR and CDRI has been ongoing since 1942, and Cipla has benefited over the years from the expertise developed at the labs of CDRI and IICT.

Two stalwarts of the CSIR with whom Cipla has been closely associated in the past have been Dr. Nitya Anand and Dr. AV Rama Rao. Now Cipla and CDRI are embarking on a futuristic program under the auspices of CSIR for the development of newer global drugs.

CDRI Collaborates With Cipla: Public-Private Partnership (PPP)

Dr. Kundu added that this collaboration was an excellent example of a Public-Private Partnership leading to the country’s progress.

This collaboration is not something new. CSIR-CDRI and Cipla have earlier for the drug delivery process. In the year 1995, chandonium iodide drug used against neuromuscular blockers as well as guggulipid drugs for hypolipidemic are some of the examples of drugs developed under one such venture. 

Editor’s Note: CDRI Collaborates With Cipla, CSIR-CDIR Cipla Collaboration